Latest filing published 27 Jun 2025 for Regulus Therapeutics Inc.. Read the official filing
No signal scores available.
This profile gathers the share dealings of Hugh Rosen in Regulus Therapeutics Inc. Over a trading history stretching from 4 December 2017 to 25 June 2025, the count stands at 4 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 27 June 2025, the filings show a transaction in Regulus Therapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations